Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-01

Clinical Trial Update: Evaluation of Vitamin A and Zinc Supplementation on Malarial Morbidity [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating vitamin A and zinc supplementation to reduce malarial morbidity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin A supplementation (Vitamin A)
  • Zinc supplementation (zinc)

Snippet

Sponsor: Kintampo Health Research Centre, Ghana | Conditions: Malaria, Malnutrition | Phase 3 | Status: COMPLETED